A Pathological Complete Response to the Combination of Ipilimumab and Nivolumab in a Patient with Metastatic Renal Cell Carcinoma

Background and Objectives: Complete pathological response after ipilimumab and nivolumab combination therapy in a patient with intermediate prognosis renal cell carcinoma is an uncommon finding. Case presentation: A 60-year-old man presented with synchronous solitary metastatic bone lesion and renal...

Descripción completa

Detalles Bibliográficos
Autores principales: Studentova, Hana, Zemankova, Anezka, Spisarova, Martina, Skanderova, Daniela, Tudos, Zbynek, Melichar, Bohuslav, Student, Vladimir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951627/
https://www.ncbi.nlm.nih.gov/pubmed/35334512
http://dx.doi.org/10.3390/medicina58030336

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951627/
https://www.ncbi.nlm.nih.gov/pubmed/35334512
http://dx.doi.org/10.3390/medicina58030336

Ejemplares similares